Quantitative Methods 2017

Heterogeneity

• The results loose credibility

• Different effect sizes in different trials • Different patient cohorts? • Different treatment efficacy? • Quality of data - How often is the TSH measured?

- In Hodgkin patients? - In H&NSCC patients? • An opportunity to learn • Which patients benefit?

• Which is the better treatment?